Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrintenstinal agents, anti-coagulants, anti-hypertensive, lipid lowering agents, vitamins, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its products. The company was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019. Kimia Biosciences Limited was incorporated in 1993 and is based in New Delhi, India.
Metrics to compare | KIMI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKIMIPeersSector | |
---|---|---|---|---|
P/E Ratio | 22.8x | 6.3x | −0.5x | |
PEG Ratio | 0.08 | 0.11 | 0.00 | |
Price/Book | 22.0x | 1.1x | 2.6x | |
Price / LTM Sales | 1.8x | 0.9x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.4% | |
Fair Value Upside | Unlock | 8.6% | 7.1% | Unlock |